Cellular Chemotaxis

Two papers detail how a cell’s gradient sensing and cytoskeletal architecture dictate one mode of chemotactic movement.

By | October 29, 2014

Dictyostelium discoideum exhibiting chemotaxisWIKIMEDIA, BRUNO IN COLUMBUSResearchers have long realized that cells can sense and move toward chemical stimuli. Now, investigators from the Johns Hopkins Medicine in Baltimore, Maryland, have shown that one mode of such movement depends on the cell’s cytoskeletal architecture, which is influenced by chemoattractant gradients.

Observing and modeling the activities of amoebas and human neutrophils, Johns Hopkins’s Ming Tang and colleagues found that, in the absence of a uniform chemoattractant, actin polymerization and chemotactic motility signaling is greatest on the side of the cell exposed to higher concentrations of the chemical. Their work was published in Nature Communications this week (October 27).

“Detecting gradients turns out to be a two-step process,” study coauthor Chuan-Hsiang Huang explained in a statement. “First, the cell tunes out the background noise, and the side of the cell that is getting less of the chemical signal just stops responding to it. Then, the control center inside the cell ramps up its response to the message it’s getting from the other side of the cell and starts the cell moving toward that signal.”

Meanwhile, a team led by Peter Devreotes of Johns Hopkins showed that inhibiting actin polymerization in human neutrophils led to uniform sensitivity to a chemoattractant. Their work is in press at Cell Reports.

(Hat tip: Science News)

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS